What is ApiJect Systems?
ApiJect Systems is a public-benefit medical technology firm dedicated to expanding access to prefilled, single-dose injections across global markets. The ApiJect Platform is engineered to empower pharmaceutical and biotech companies in designing scalable prefilled injectors and executing efficient fill-finish processes for their injectable drug products. This capability can be leveraged through the company's ApiJect-licensed Blow-Fill-Seal packaging lines or via its network of world-class manufacturing partners, aiming to streamline drug delivery and enhance patient accessibility.
How much funding has ApiJect Systems raised?
ApiJect Systems has raised a total of $111M across 1 funding round:
Other Financing Round
$111M
Other Financing Round (2022): $111M with participation from Jefferies and Royalty Pharma
Key Investors in ApiJect Systems
Jefferies
Jefferies is a global investment banking and capital markets firm that provides a wide range of financial advisory and capital raising services. Their involvement suggests a strategic financial backing for ApiJect's growth and market expansion initiatives.
Royalty Pharma
Royalty Pharma is a leading funder of innovation in the biopharmaceutical industry, specializing in acquiring royalties and co-funding late-stage clinical trials and product launches. Their participation indicates confidence in ApiJect's technology and its potential to generate significant future revenue streams.
What's next for ApiJect Systems?
The substantial enterprise-level funding and recent strategic investment position ApiJect Systems for significant expansion and operational scaling. This capital infusion is expected to accelerate the development and deployment of its innovative injection platform, potentially enabling broader adoption by pharmaceutical partners. The company's focus on scalable prefilled injectors suggests a strategic push to capture a larger share of the drug delivery market, particularly for single-dose injectables, and to enhance global healthcare accessibility.
See full ApiJect Systems company page
